Pacira BioSciences (PCRX) earnings, Sep 30, 2026: EPS −14%, stock −2.3%
In brief
Pacira BioSciences reported on Sep 30, 2026. Earnings per share changed −14% year over year, 17.9% below the estimate; revenue −2%. The stock opened with a −0.2% gap and closed the day −2.3% (Sep 30, 2026). The stock is now 0.5% below its 52-week high, +58.2% over 12 months. Next report: Nov 11, 2026.
EPS vs estimate−17.9%
EPS, YoY−14%
Revenue, YoY−2%
Gap · day−0.2% · −2.3%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 4, 2026 | −5.6% | −10.0% |
| Sep 30, 2026 | −0.2% | −2.3% |
Next-quarter estimates, ratings and the PCRX chart are in the terminal.
Open the terminalFAQ
When is Pacira BioSciences's next earnings report?
Nov 11, 2026. The date comes from daily data and is corrected if the company moves it.
How did Pacira BioSciences stock react to the report?
Opening gap −0.2%, day's result −2.3%.
Did Pacira BioSciences's earnings grow?
Earnings per share fell 14% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.